Anthrogenesis Corporation Information

Anthrogenesis, based in Cedar Knolls, New Jersey, is a biotherapeutics company that has developed proprietary methods for collecting, processing and storing stem cells and other valuable biomaterials derived from human placental tissue, and has pioneered the recovery of non-adult human pluripotent and multipontent stem cells from that tissue. Anthrogenesis is focused on developing and delivering therapies using stem cells sourced from human placental tissue to treat cancers and immunological, metabolic and inflammatory diseases. Anthrogenesis has demonstrated that the human placenta is an abundant source of biotherapies, including early stage stem cells and other biomaterials for organ and tissue repair. Anthrogenesis also operates Lifebank, a state-licensed blood bank that banks stem cell transplant units derived from placental tissue and in some cases, blood from the umbilical cord that is collected immediately after birth. Anthrogenesis also focuses on cell therapeutics and regenerative medicine, for which it is implementing primary strategies in pluripotent and multipontent stem cell therapy. It has a complimentary effort in bioengineered amniotic membranes, a human tissue that it recovers from postnatal placentas and fabricates for use as a cell therapy delivery platform.